Applied Dna Sciences Stock Analysis

Applied Stock Analysis Notes

About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.88. Some equities with similar Price to Book (P/B) outperform the market in the long run. Applied DNA Sciences recorded a loss per share of 7.5. The entity last dividend was issued on the 1st of November 2019. The firm had 1:20 split on the 25th of April 2024. Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York. Applied Dna operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 78 people. For more info on Applied DNA Sciences please contact the company at 631 240 8800 or go to https://www.adnas.com.

Applied DNA Sciences Investment Alerts

Applied DNA Sciences Upcoming and Recent Events

Applied Largest EPS Surprises

View All Earnings Estimates

Applied Stock Institutional Investors

Note, although Applied DNA's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Applied Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.37 M.

Applied Profitablity

The company has Profit Margin (PM) of (2.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (4.2) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $4.2.

Management Efficiency

Applied DNA Sciences has return on total asset (ROA) of (0.5744) % which means that it has lost $0.5744 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7608) %, meaning that it created substantial loss on money invested by shareholders. Applied DNA's management efficiency ratios could be used to measure how well Applied DNA manages its routine affairs as well as how well it operates its assets and liabilities. As of the 13th of December 2024, Return On Tangible Assets is likely to drop to -66.75. In addition to that, Return On Capital Employed is likely to grow to -60.39. At this time, Applied DNA's Intangibles To Total Assets are very stable compared to the past year. As of the 13th of December 2024, Asset Turnover is likely to grow to 0.93, while Total Current Assets are likely to drop about 5 M.

Technical Drivers

As of the 13th of December 2024, Applied DNA shows the Risk Adjusted Performance of (0.13), mean deviation of 7.15, and Standard Deviation of 11.37. Applied DNA Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Applied DNA Sciences Price Movement Analysis

Applied DNA Sciences Insider Trading Activities

Applied DNA Outstanding Bonds

Applied DNA Predictive Daily Indicators

Applied DNA Forecast Models

Applied DNA's time-series forecasting models are one of many Applied DNA's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Applied DNA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Applied DNA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Applied shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Applied DNA. By using and applying Applied Stock analysis, traders can create a robust methodology for identifying Applied entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Applied analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Applied analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Applied DNA Sciences stock analysis indicators help investors evaluate how Applied DNA stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Applied DNA shares will generate the highest return on investment. By understating and applying Applied DNA stock analysis, traders can identify Applied DNA position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.